• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

MicroTransponder Inc.

MicroTransponder has positive results for its stroke-recovery neurostim

May 8, 2025 By Carrie Pallardy

MicroTransponder has reported the results of a one-year follow-up study of its Vivistim Paired VNS System for chronic stroke recovery, revealing improvement in chronic stroke survivors with motor impairment. The Vivistim system, an implantable device, initially received FDA approval in 2021. The study findings, published in Stroke and announced by the company yesterday, validate Paired […]

Filed Under: Clinical Trials, Neuromodulation/Neurostimulation Tagged With: MicroTransponder Inc., Stroke

MicroTransponder raises $65M for nerve stim tech

March 12, 2025 By Sean Whooley

MicroTransponder announced today that it raised $65 million in a Series F financing round to support its Vivistim system. Vivistim, a vagus nerve stimulation (VNS) system, aims to help ischemic stroke survivors improve hand and arm function when paired with occupational or physical therapy. Paired VNS helps increase neuroplasticity, enabling stroke survivors to make gains […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Neurological, Neuromodulation/Neurostimulation Tagged With: MicroTransponder Inc.

MicroTransponder Vivistim nerve stim tech delivers positive stroke outcomes

February 7, 2025 By Sean Whooley

MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system. Data highlighted Vivistim’s impact when paired with occupational or physical therapy to help ischemic stroke survivors improve hand and arm function. The study demonstrated 2-3 times improved arm function compared to traditional stroke therapy alone. Dr. Ronald P. Benitez presented safety […]

Filed Under: Clinical Trials, Implants, Neurological, Neuromodulation/Neurostimulation Tagged With: MicroTransponder Inc.

MicroTransponder reports first commercial implantation of its stroke rehab neurostim system

May 20, 2022 By Chris Newmarker

MicroTransponder (Austin, Texas) recently announced the first commercial implantation of its Vivistim paired VNS system for chronic ischemic stroke rehabilitation. Dr. Charles Y. Liu, director of the University of Southern California Neurorestoration Center, and Dr. Jonathan J. Russin, director of the USC Neuro Revascularization Center, successfully placed the small Vivistim device under the skin of […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Neuromodulation/Neurostimulation, News Well Tagged With: MicroTransponder Inc., Stroke

FDA approves MicroTransponder’s stroke rehab neurostim system

August 27, 2021 By Sean Whooley

The FDA announced today that it approved the MicroTransponder Vivistim paired VNS system for chronic ischemic stroke rehabilitation. MicroTransponder designed its Vivistim System as a first-of-its-kind, drug-free rehabilitation system for treating moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulation, according to an FDA news release. Vivistim electrically […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: FDA, MicroTransponder Inc.

Neurostimulation may help restore arm function years after stroke

April 27, 2021 By Nancy Crotti

Stroke survivors who received vagus nerve stimulation (VNS) combined with rehabilitation had better arm and hand function, according to the results of a new study. In the international, multi-center clinical trial, 53 participants with moderate to severe arm weakness nine months to 10 years post-stroke received rehabilitation paired with VNS. Fifty-five patients within the same […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Featured, Neuromodulation/Neurostimulation Tagged With: MicroTransponder Inc.

7 medtech stories we missed this week: June 2, 2017

June 2, 2017 By Danielle Kirsh

From Implandata receiving CE Marking to Inolife eyeing up-listing, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Dextera seeks expanded indications for MicroCutter 5/80 stapler Dextera Surgical announced in a June 1 press release that it has filed a 510(k) with the FDA for its MicroCutter 5/80 stapler. The […]

Filed Under: Business/Financial News, Clinical Trials, News Well, Regulatory/Compliance, Research & Development Tagged With: c2 Therapeutics, dextera, DreaMed Diabetes, endogastricsolutions, Implandata, Inolife, MicroTransponder Inc.

Neuravi closes $6.5M round for clot retrieval | Funding Roundup

July 11, 2012 By MassDevice staff Leave a Comment

Funding Roundup

 Neuravi successfully completes Series A financing

Irish medical device company Neuravi Limited successfully completed a Series A financing round for $6.5 million (€5.2 million).

Filed Under: Funding Roundup, News Well Tagged With: MicroTransponder Inc., Neuravi Limited, Terumo

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy